Gene structure and transcriptional regulation of human Gal β1,4(3) GlcNac α2,3-sialyltransferase VI (hST3Gal VI) gene in prostate cancer cell line

Biochemical and Biophysical Research Communications

Volumn 287, Issue 5, 2001, Pages 1148-1156

  Taniguchi, Akiyoshi ^a   Kaneta, Reiko ^a   Morishita, Kayoko ^a   Matsumoto, Kojiro ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Dual promoter; Gene regulation; Luciferase assay; Multiple mRNA isoforms; Sialic acid

Indexed keywords

LUCIFERASE; MESSENGER RNA; SIALIC ACID; SIALYLTRANSFERASE;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; GENE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 0035850771     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5709     Document Type: Article

References (42)

1. Differential expression of five sialyltransferase genes in human tissues
2. Three genes that encode human beta-galactoside alpha 2,3-sialyltransferases. Structural analysis and chromosomal mapping studies
3. Molecular cloning and expression of human Gal beta 1,3 GalNAc alpha 2,3-sialyltransferase (hST3Gal II)
4. Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase
5. Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection
6. Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups
7. Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthase
8. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids
9. Down-regulation of human sialyltransferase gene expression during in vitro human keratinocyte cell line differentiation
10. Differentiation elicits negative regulation of human beta-galactoside alpha2,6-sialyltransferase at the mRNA level in the HL-60 cell line
11. Human colon cancer cell line permanently expressing alpha2,6-sialylated sugar chains by transfection with rat beta-galactoside alpha2,6-sialyltransferase cDNA
12. Downregulation of a human colonic sialyltransferase by a secondary bile acid and a phorbol ester
13. Differentiation-dependent expression of human beta-galactoside alpha2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells
14. Up-regulation of alpha 2,6-sialylation during myeloid maturation: A potential role in myeloid cell release from the bone marrow
15. Immune regulation by the ST6Gal sialyltransferase
16. Characterization of terminal sialic acid linkages on human thymocytes. Correlation between lectinbinding phenotype and sialyltransferase expression
17. The ST3Gal-I sialyltransferase controls CD8 + T lymphocyte homeostasis by modulating O-glycan biosynthesis
18. Tissue-specific expression of sialyltransferases
19. Genomic organization and chromosomal mapping of the Gal beta 1,3GalNAc/Gal beta 1,4GlcNAc alpha2,3-sialyltransferase
20. Cell-specific expression of human β-galactoside α2,6-sialyltransferase transcripts differing in the 5′ untranslated region
21. Chromosome mapping and organization of the human β-galactoside α2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells
22. Transcription of the beta-galactoside alpha 2,6-sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter
23. Characterization of a promoter region supporting transcription of a novel human beta-galactoside alpha-2,6-sialyltransferase transcript in HepG2 cells
24. Transcriptional regulation of human beta-galactoside alpha2, 6-sialyltransferase (hST6Gal I) gene during differentiation of the HL-60 cell line
25. Epithelial-cell-specific transcriptional regulation of human Galbetal,3GalNAc/Galbeta1,4GlcNAc alpha2,3-sialyltransferase (hST3Gal IV) gene
26. Down-regulation of human Galbeta1,3GalNAc/Galbeta1,4GlcNAc alpha2,3-sialyltransferase (hST3Gal IV) gene during differentiation of the HL-60 cell line
27. Differential gene expression of a human alpha2,3-sialyltransferase in leukaemic cell lines and leucocytes
28. Expression and transcriptional regulation of the human alpha1,3-fucosyltransferase 4 (FUT4) gene in myeloid and colon adenocarcinoma cell lines
29. Genomic structure and transcriptional regulation of human Galβ1,3GalNAc α2,3-sialyltransferase (hST3Gal I) gene
30. Changing transcription start sites in H-type alpha (1,2) fucosyltransferase gene (FUT1) during differentiation of the human erythroid lineage
31. Prostate-specific antigen. Its discovery and biochemical characteristics
32. Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells
33. Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era
34. Prostate-specific membrane antigen and other prostatic tumor markers on the horizon
35. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen
36. Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase
37. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
38. Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene
39. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein
40. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line
41. The molecular biology of urological tumors
42. Prostate-specific antigen expression is regulated by an upstream enhancer